Trial Details

COMPLETED
Basic Information
Clinical ID c3275
Identifier NCT02302404
Trial Title A Safety and Tolerability Study of GSK2982772, in Single (in Both Fed and Fasted States) and Repeat Oral Doses in Healthy Male Subjects
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Inflammatory Bowel Diseases
Interventions DRUG: GSK2982772 solution|DRUG: GSK2982772 capsule|DRUG: Placebo solution|DRUG: Placebo capsule
Participant Information
Sponsor GlaxoSmithKline
City Cambridge
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement MALE
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2015-01-06
Primary Completion Date 2016-03-05
Completion Date 2016-03-05